Light AI announced a company-funded field study in New Zealand for its QuickScan™ Strep A platform. The study will evaluate the platform's performance in a real-world clinical setting. This initiative aims to gather data on the diagnostic technology for strep throat detection.
Tap to vote and see what everyone thinks.
Summary by ByteBrief
Compugen CEO on AI-Driven Target Discovery